메뉴 건너뛰기
British Journal of Dermatology
Volumn 156, Issue 6, 2007, Pages 1389-
Safety of calcineurin inhibitors in the management of lichen sclerosis [17]
Author keywords

[No Author keywords available]
Indexed keywords

CALCINEURIN INHIBITOR; TACROLIMUS;
EID: 34447092259     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07912.x     Document Type: Letter
Times cited : (11)
References (9)
  • 1
    • 33749828583 scopus 로고    scopus 로고
    • Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus
    • Hengge UR, Krause W, Hofmann H et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006 155 : 1021 8.
    • (2006) Br J Dermatol , vol.155 , pp. 1021-1028
    • Hengge, U.R.1    Krause, W.2    Hofmann, H.3
  • 3
    • 13244262708 scopus 로고    scopus 로고
    • Herpes simplex of the vulva evoked by topical tacrolimus treatment
    • Lonsdale-Eccles AA, Velangi SS. Herpes simplex of the vulva evoked by topical tacrolimus treatment. Clin Exp Dermatol 2005 30 : 95 6.
    • (2005) Clin Exp Dermatol , vol.30 , pp. 95-96
    • Lonsdale-Eccles, A.A.1    Velangi, S.S.2
  • 4
    • 0036022552 scopus 로고    scopus 로고
    • Relapsing Kaposis's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis
    • Ambo M. Relapsing Kaposis's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis. Acta Derm Venereol 2002 82 : 224 5.
    • (2002) Acta Derm Venereol , vol.82 , pp. 224-225
    • Ambo, M.1
  • 5
    • 30644474051 scopus 로고    scopus 로고
    • Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream
    • Segura S, Romero D, Carrera C et al. Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream. Acta Derm Venereol 2005 85 : 524 5.
    • (2005) Acta Derm Venereol , vol.85 , pp. 524-525
    • Segura, S.1    Romero, D.2    Carrera, C.3
  • 6
    • 26244448556 scopus 로고    scopus 로고
    • Topical tacrolimus and pimecrolimus and the risk of cancer: How much cause for concern
    • Ormerod AD. Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern. Br J Dermatol 2005 153 : 701 5.
    • (2005) Br J Dermatol , vol.153 , pp. 701-705
    • Ormerod, A.D.1
  • 7
    • 33750963669 scopus 로고    scopus 로고
    • Topical tacrolimus (Protopic) and pimecrolimus (Elidel): Reports of malignancies
    • Commission on Human Medicines.
    • Commission on Human Medicines. Topical tacrolimus (Protopic) and pimecrolimus (Elidel): reports of malignancies. Current Problems in Pharmacovigilance 2006 31 : 1 2.
    • (2006) Current Problems in Pharmacovigilance , vol.31 , pp. 1-2
  • 8
    • 33745494144 scopus 로고    scopus 로고
    • Topical tacrolimus in the management of lichen sclerosus
    • Luesley DM, Downey GP. Topical tacrolimus in the management of lichen sclerosus. Br J Obstet Gynaecol 2006 113 : 832 4.
    • (2006) Br J Obstet Gynaecol , vol.113 , pp. 832-834
    • Luesley, D.M.1    Downey, G.P.2
  • 9
    • 0036405032 scopus 로고    scopus 로고
    • British Association of Dermatologists. Guidelines for the management of lichen sclerosus
    • Neill SM, Tatnall FM, Cox NH. British Association of Dermatologists. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002 147 : 640 9.
    • (2002) Br J Dermatol , vol.147 , pp. 640-649
    • Neill, S.M.1    Tatnall, F.M.2    Cox, N.H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.